Promising growth and investment in the cell therapy industry during the first quarter of 2012.

Cell Stem Cell. 2012 May 4;10(5):492-6.

Promising growth and investment in the cell therapy industry during the first quarter of 2012.

Brindley DA, Davie NL, Sahlman WA, Bonfiglio GA, Culme-Seymour EJ, Reeve BC, Mason C.

Abstract

Abstract:

In the first quarter of 2012, publicly traded companies in the cell-based therapy industry continued to show promising overall growth. Highlights included $85 million in new capital investment and steady clinical trial progress.